Disease Description (Causes and Symptoms)
Precocious puberty is a condition in which secondary sexual characteristics begin earlier than expected. The age criteria are the onset of secondary sexual characteristics (such as breast development in girls and testicular enlargement in boys) before age 8 in girls and before age 9 in boys.
Main classifications and pathophysiology:
- Central (true) precocious puberty: A form in which GnRH secretion from the hypothalamus and pituitary is activated prematurely, causing LH/FSH and sex hormones to rise (GnRH-dependent). It is mostly idiopathic, but central lesions such as brain tumors or cysts may be the cause (particularly suspected in boys and very young children).
- Peripheral (pseudo) precocious puberty: Occurs when sex hormones are excessively secreted by the gonads or other organs (ovarian or testicular tumors, adrenal hyperfunction, McCune-Albright syndrome, etc.) (GnRH-independent).
Main symptoms: Early appearance of secondary sexual characteristics (breast development, pubic or axillary hair, and enlargement of the scrotum and testes in boys), rapid acceleration of growth (initially tall stature), and advanced bone age → potentially reduced final adult height. Obesity and environmental endocrine-disrupting chemicals may affect the development of the condition.
Treatment Methods
Goal: To slow the progression of secondary sexual characteristics and the rate of bone maturation by suppressing sex hormone activity, thereby securing normal final height and minimizing psychosocial problems.
-
Central precocious puberty (standard treatment)
- GnRH agonists (long-acting GnRH analogues): Examples include leuprolide and triptorelin. Usually administered by subcutaneous or intramuscular injection every month (or as a 3-month formulation). Continuous stimulation causes receptor desensitization → suppression of LH/FSH and sex hormone secretion.
- Treatment effects: Reduced growth velocity, delayed progression of bone age, and cessation or regression of secondary sexual characteristics.
- Treatment duration: Determined individually (considering bone age, growth potential, symptoms, etc.). Puberty may resume within several months after treatment is discontinued (the timing varies, from an average of several months to several years; for example, menstruation may begin approximately 18 months later according to some literature).
-
Peripheral precocious puberty
- Treatment of the underlying disease (ovarian, adrenal, or genital tumors, McCune-Albright syndrome, etc.) (surgery or medical treatment).
- If necessary, hormone suppression or symptomatic treatment based on the underlying cause may be provided concurrently.
-
Additional and supportive management
- Regular monitoring of growth and bone age, and monitoring of treatment response through sex hormone and LH/FSH tests.
- Obesity management (weight loss and exercise) and recommendations to minimize exposure to environmental hormones (plastic products, pesticides, etc.).
- Psychosocial support (counseling for peer relationships and emotional issues).
Precautions (Clinical Considerations)
- Medication must be administered regularly; irregular administration may instead stimulate puberty.
- Side effects are uncommon, but injection-site reactions, mild vaginal bleeding, or breast changes may occur.
- Brain MRI is recommended to check for central lesions in boys (in particular) and very young girls.
- Because growth and reproductive function outcomes after treatment discontinuation vary among individuals, consultation with a specialist is necessary.
Checklist Before an Outpatient Visit (Including Example Questions)
Preparation and information to organize in advance
- List of currently used medications and supplements (including dosage and duration of use).
- Past medical history (birth history, neurological problems, and chronic diseases) and family history (including the age at which puberty began).
- Timing and progression of symptoms (when they began, which symptom appeared first, and how quickly they progressed), whether menstruation has occurred, and the date of the first menstrual period (if applicable).
- Growth records (previous height and weight records and growth charts) and previous test results (bone age images, hormone tests, ultrasound/MRI, etc.).
- Recording changes in secondary sexual characteristics over time with photographs (if necessary) may help with diagnosis.
- The hospital may provide separate instructions before tests, such as whether fasting is required before the outpatient visit (check the instructions before hormone or stimulation tests).
Example questions (including questions to ask the doctor directly during the outpatient visit)
- How do you distinguish whether this condition is central or peripheral?
- Is an MRI or any additional testing necessary?
- How should I prepare for a hormone stimulation test (GnRH stimulation test)?
Examples of General Questions to Ask the Doctor
- What are the expected side effects of this medication (or injection), and how should they be managed?
- How long does treatment usually last? When should it be discontinued?
- How likely is treatment to affect final height (growth outcome)?
- What regular tests are needed during treatment (frequency and items)?
Examples of Condition-Specific Questions
- Brain MRI is recommended for boys. At what neurological findings or age criteria is it essential to perform one?
- What information (bone age, parents' heights, etc.) should be prepared to predict the improvement in growth potential (final height) after GnRH analogue treatment?